AskTheDate.com
Back to calendar

IRulya Therapeutics Inc. (IRLA) Earnings

IRLA reports earnings on Wednesday, November 18, 2026

earnings report
November 18, 2026 · Before Market Open
Q3 2026
Est. EPS: $-1.39
Actual EPS: $-12.31
EPS surprise: 56.07%
Company overview
Market Cap$32.2M
PriceUSD 31.67
EPS (TTM)-125.60
52-week high909.98
52-week low15.10
SectorHealth Technology
IndustryBiotechnology
Employees38
Buy me a coffee